{
  "ticker": "AFP",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02975666",
  "id": "02975666",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250801",
  "time": "0730",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250801/pdf/06mdwwc2rtwrgv.pdf",
  "summary": "- **FY26 operating profit guidance**: $20.0 to $24.0 million.  \n- **Revenue target for FY27**: $300 million.  \n- **R&D pipeline**: Targets addressable markets worth over **US$8 billion**, with 8 patented products and 24 off-patent injectables in development.  \n- **Key commercialisation programs**: Maxigesic\u00ae, Crystaderm\u00ae, Micolette\u00ae, Kiwisoothe\u00ae, and capsaicin cream.  \n\n*No material capital markets or trading-specific actions identified (e.g., capital raising, trading halt).*",
  "usage": {
    "prompt_tokens": 1072,
    "completion_tokens": 122,
    "total_tokens": 1194,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-31T21:46:03.455663"
}